An In Vitro Engineered Osteochondral Model as Tool to Study Osteoarthritis Environment

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Osteoarthritis Research

Background:

• Osteoarthritis (OA) is a degenerative joint disease impacting articular cartilage (AC) and subchondral bone (SB).
• Current models lack the predictive capability needed to identify effective pharmacological targets for OA.
• A biomimetic in vitro model is crucial for advancing OA research and therapeutic development.

Purpose of the Study:

• To develop a novel biomimetic in vitro model of the articular cartilage and subchondral bone interface.
• To simulate healthy and pathological conditions of the joint, including cytokine-induced osteoarthritis.
• To provide a more predictive tool for studying OA development and progression.

Main Methods:

• Fabrication of a dual-component hydrogel system using gellan gum methacrylated, chondroitin sulfate/dopamine for AC, and functionalized polylactic acid for SB.
• Utilizing immortalized stem cells (Y201s) and differentiated chondrocytes (Y201-Cs) to mimic SB and AC physiology, respectively.
• Culturing cells in vitro for 21 days under healthy and pathological (cytokine-induced OA) conditions.

Main Results:

• Demonstrated physiological behavior of stem cells and chondrocytes in the biomimetic model over 21 days.
• Observed reduced glycosaminoglycans production and increased calcification (Collagen X) in the AC deep layer under pathological conditions.
• Detected elevated pro-angiogenic factor (VEGF) and decreased osteogenic markers (Coll1, SPP1, RUNX2) in the SB under pathological conditions.

Conclusions:

• The developed biomimetic in vitro model accurately replicates key features of osteoarthritis at the AC-SB interface.
• This model serves as a valuable new tool for investigating OA pathogenesis and evaluating potential therapeutic strategies.
• The model's predictive capabilities can accelerate the identification of pharmacological targets for osteoarthritis treatment.